Eight-week-old male Wistar-Kyoto rats (WKYs) and spontaneously hypertensive rats (SHRs) were purchased from Vital River Laboratory (Beijing, China). After animals were anesthetized by pentobarbital sodium (60 mg/kg, i.p.), aortas, hearts, brains, kidneys, and livers were detached and immediately frozen in liquid nitrogen for real-time reverse transcription-polymerase chain reaction (real-time RT-PCR) or western blot analysis. Animal experiments in this study were performed according to the guidelines of the Animal Ethics Committee of Capital Medical University.
TaqMan real-time RT-PCR
Total RNA was extracted from frozen rat tissues using Trizol reagent (Invitrogen, Carlsbad, CA). One microgram of total RNA was converted to cDNA by reverse transcription reaction with the PrimeScript 1st Strand cDNA Synthesis Kit (Takara, Kyoto, Japan) following the manufacturer's instructions. Subsequently, relative expression levels of ANTXR2 in WKY and SHR rats were determined by TaqMan quantitative real-time RT-PCR on an ABI Prism 7,500 sequence detection system (Applied Biosystems, Foster, CA). Gene specific TaqMan Gene Expression Assays were obtained from Applied Biosystems and the comparative 2 −ΔΔCt method was used to quantify the relative mRNA expression with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an endogenous control.
Western blot analysis
Total protein was extracted from rat tissues using lysis buffer containing protease inhibitor cocktail and quantified by the BCA protein assay as previously reported. 21 Proteins were separated on a 4-12% gradient sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes (Millipore, Billerica, MA), which were subsequently incubated with anti-ANTXR2 (1:2000, cat. no. ab70499, Abcam, Cambridge, MA) or anti-GAPDH (1:5000, M2006, Abmart, Shanghai, China) at 4 °C for 12 hours. After binding with appropriate secondary antibody, detection was performed using the Odyssey infrared imaging system (LI-COR Biosciences).
Generation and validation of ANTXR2 knock-out rats
ANTXR2 knock-out rats were created using CRISPR/ Cas9-mediated genome editing. Briefly, exon 1 of the rat ANTXR2 gene was selected as the Cas9-targeting region and 2 guide RNA target sequences within exon 1 were designed based on the CRISPR Design Tool. Two guide RNA targeting vectors were specifically engineered for guided Cas9-mediated genome editing. The guide RNA targeting vectors and Cas9 were co-injected into the fertilized eggs to generate ANTXR2 knock-out rats. The pups were genotyped by PCR and confirmed by sequencing (forward primer: 5′-TTGGGTGGCTCTGAGCTTGGA-3′, reverse primer: 5′-AGGGGTCTAGGGGAGTGTGATAAAGA-3′).
Osmotic pump implantation
Eight-week-old wild type (WT) or ANTXR2 −/− rats were anesthetized using isoflurane and osmotic pumps (model 2002, Alzet) containing Angiotensin II (Ang II, Abcam) at a concentration sufficient to allow an infusion rate of 400 ng/ kg/min for 14 days were implanted subcutaneously at the dorsum of the neck.
High-salt treatment
Eight-week-old WT or ANTXR2 −/− rats were treated with AIN-76A high-salt (HS, 8% NaCl) diet for 4 weeks, and blood pressure was measured by tail-cuff method at 8, 9, 10, 11, and 12 weeks old and by carotid arterial catheterization method at the end of treatment.
Tail-cuff blood pressure measurement
In conscious rats, systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate were measured once per week at basal conditions and during HS diet treatment or every other day during Ang II infusion by a computerized tail-cuff system (Softron, Tokyo, Japan) and mean blood pressure (MBP) was calculated. In accordance with the manufacture's recommendation, rats were trained for a minimum of 3 consecutive days in the prewarmed tail-cuff device prior to official detection. Measurements were performed at the same time of day, and on each day of blood pressure determination, 10 measurements were obtained and averaged for each rat.
Carotid arterial catheterization blood pressure measurement
At the end of this study, invasive blood pressure was measured with a physiological data acquisition and analysis system to confirm the results acquired by tail-cuff method. In brief, animals were anesthetized with isoflurane and placed on a temperature-controlled pad. A polyethylene tube prefilled with heparinized normal saline was inserted into the carotid artery, and blood pressure was measured with a Cobe CDX II transducer connected to a PowerLab system (LabChart 7.3.5, AD Instruments). Blood pressure was recorded for 30-60 minutes after stable values were obtained.
Statistical analysis
Statistical analysis was conducted with Prism (GraphPad, Software, La Jolla, CA). Data were presented as mean ± SEM. Comparisons between 2 groups were evaluated using 2-sided Student t test. A P < 0.05 was required to reject the null hypothesis and thus considered a statistically significant value.
RESULTS

Expression of ANTXR2 in tissues of hypertensive rats
The mRNA and protein expression levels of ANTXR2 in tissues of SHRs and WKYs were determined by real-time RT-PCR and western blot analysis, respectively. As demonstrated in Figure 1 , neither the mRNA nor protein levels of ANTXR2 were significantly different between vessels, brains, hearts, kidneys, and livers from SHRs and WKYs.
Generation and verification of ANTXR2 knock-out rats
ANTXR2 knock-out rats were generated using CRISPR/ Cas9-mediated genome editing. Specifically, a 67 base pairs deletion in exon 1 of ANTXR2 was induced by genome editing, which was confirmed by PCR and sequencing (Figure 2a) . Western blot analysis demonstrated that ANTXR2 protein decreased significantly in the aortas of ANTXR2 −/− rats, suggesting sufficient efficiency of ANTXR2 knock-out ( Figure 2b) .
As reported previously, 16, 22 ANTXR2 −/− female rats generated by CRISPR/Cas9-mediated genome editing exhibited a failure in parturition, while ANTXR2 +/− female rats were fertile, further confirmed that ANTXR2-null rats were generated successfully. Therefore, ANTXR2 −/− rats were obtained by mating ANTXR2 −/− female rats with ANTXR2 −/− male rats or intercrossing of ANTXR2 +/− rats.
Blood pressure in ANTXR2 −/− rats at basal state
The blood pressure of both ANTXR2 −/− and WT rats were measured by tail-cuff method at 7, 8, 9, and 10 weeks old and by carotid artery catheterization at 10 weeks old. As depicted in Figure 3 , male ANTXR2 −/− rats exhibited nearly the same SBP, DBP, MBP, and heart rate as WT rats at basal state as determined by either tail-cuff method or carotid arterial catheterization method. The results of female rats were comparable to those obtained for male rats (data not shown).
Blood pressure in ANTXR2 −/− rats during infusion of Ang II
To investigate blood pressure responses to continuous Ang II infusion, osmotic minipumps were implanted subcutaneously into WT and ANTXR2 −/− rats. Ang II was infused at a rate of 400 ng/kg/min for 2 weeks. On initiation of Ang II delivery, SBP, DBP, and MBP values rose progressively to almost 228, 179, and 196 mm Hg, respectively, and remained elevated throughout the study (Figure 4a-c) . However, the increments of SBP, DBP, and MBP were similar in WT and ANTXR2 −/− rats (Figure 4a-c) . Blood pressures determined by carotid artery catheterization at the end of Ang II infusion showed the same results as that measured by tail-cuff method (Figure 4d ).
Blood pressure in ANTXR2 −/− rats during HS diet treatment
To investigate blood pressure responses to HS diet treatment, 8-week old WT or ANTXR2 −/− rats were fed 8% salt AIN-76A for 4 weeks. As shown in Supplementary Figure S1a−c, there were no significant differences of SBP, DBP, and MBP between WT and ANTXT2 −/− rats as determined by tail-cuff method during the 4-week HS diet treatment. Blood pressures determined by carotid artery catheterization at the end of HS diet treatment showed the same results as that measured by tail-cuff method (Supplementary Figure S1d) .
DISCUSSION
Herein our study suggested that ANTRX2 knock-out did not impact, nor result in hypertension in a rat model. We demonstrated that: (i) neither the mRNA nor protein levels of ANTXR2 were significantly different between tissues from SHRs and WKYs and (ii) ANTXR2 −/− rats exhibited nearly the same blood pressure as WT rats at basal conditions as well as during infusion with Ang II (400 ng/kg/min) or treatment with HS diet. Taken together, our data therefore do not support a direct causal role of ANTXR2 in blood pressure. SHR is the most widely used animal model of human essential hypertension. 23 Accordingly, the expression pattern of ANTXR2 was determined in SHR tissues including vessels, brains, hearts, kidneys, and livers. Nevertheless, both the mRNA and protein levels of ANTXR2 were almost the same between SHRs and WKYs in the tissues detected.
Female ANTXR2 −/− rats generated by CRISPR/Cas9-mediated genome editing could be pregnant but were unable to deliver pups. This was consistent with previous reports that ANTXR2 −/− female mice were unable to produce any offspring due to a defect in parturition. 16, 22 Ultimately, these results further confirm the successful generation of ANTXR2-null rats in this study.
Examination of WT vs. ANTXR2 −/− rats revealed nearly identical BP profiles at baseline conditions as well as during Ang II infusion or HS diet treatment. These results suggest that ANTXR2 is unlikely to be the hypertension-causative gene at the 4q21 locus. This is at odds with previously published reports that have demonstrated an increase in BP in mice injected with ANTXR2-small interfering RNA. 18 The reasons for this discrepancy remain unknown, though differences between small interfering RNA (previously published WT rats as determined by tail-cuff method at 7-10 weeks old (n = 7 each group, NS: P > 0.05). (e)ANTXR2 −/− rats exhibited nearly the same BW as WT rats at 7-10 weeks old (n = 7 each group, NS: P > 0.05). (f) ANTXR2 −/− rats exhibited nearly the same SBP, DBP, and MBP as WT rats as determined by carotid arterial catheterization method at 10 weeks old (n = 7 each group, NS: P > 0.05). Abbreviations: ANTXR2, anthrax toxin receptor 2; BW, body weight; DBP, diastolic blood pressure; HR, heart rate; MBP, mean blood pressure; NS, nonsignificant; SBP, systolic blood pressure; WT, wild type. reports) and gene knock-out (present study) to abrogate gene function may in part explain these differences.
Collectively, results from this research suggest that ANTXR2 is unlikely to be the hypertension-causative gene at the 4q21 locus. Clearly, further studies are required to understand the role of ANTXR2 and the single nucleotide polymorphism rs16998073 in BP regulation.
SUPPLEMENTARY MATERIALS
Supplementary materials are available at American Journal of Hypertension (http://ajh.oxfordjournals.org). WT and ANTXR2 −/− rats during the 14-day infusion of Ang II (400 ng/kg/min) as determined by tail-cuff method (n = 6 each group, NS: P > 0.05). (e) SBP, DBP, and MBP in ANTXR2 −/− were not different from those in WT group as determined by carotid arterial catheterization after a 14-day infusion of Ang II (400 ng/kg/min) (n = 6 each group, NS: P > 0.05). Abbreviations: Ang II, angiotensin II; ANTXR2, anthrax toxin receptor 2; DBP, diastolic blood pressure; MBP, mean blood pressure; NS, nonsignificant; SBP, systolic blood pressure; WT, wild type.
